MOMA Therapeutics

About:

MOMA Therapeutics operates as a biotechnology company.

Twitter/X: moma_tx

Top Investors: Alexandria Venture Investments, Cormorant Asset Management, Invus, Section 32, Casdin Capital

Description:

MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.

Total Funding Amount:

$236M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2020-01-01

Founders:

Dorothee Kern, Eva Nogales, Johannes Walter, Timur Yusufzai

Number of Employees:

11-50

Last Funding Date:

2022-05-10

IPO Status:

Private

Industries: